About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Detroit | 7,243 Studies Near You

Clinical TrialsDetroit

Clinical Trials in Detroit

Discover 7,243 clinical trials near Detroit, Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3141-3160 of 7,243 trials

RecruitingSacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of…NCT06393374·Mobile, Alabama and 310 others

Find Trials by Condition in Detroit

Breast Cancerin Detroit Lung Cancerin Detroit Prostate Cancerin Detroit Colorectal Cancerin Detroit Melanomain Detroit Leukemiain Detroit Lymphomain Detroit Pancreatic Cancerin Detroit Ovarian Cancerin Detroit Brain Cancerin Detroit Diabetes

Data from ClinicalTrials.govTerms

TerminatedREDAPT Retrospective-Prospective Modular Stem StudyA Retrospective-Prospective Study of REDAPT Revision Femoral System Modular Stem is a post-market, retrospective-prospective, multi-center, single arm, consecutive series study…NCT02661620·Louisville, Kentucky and 4 others

CompletedPrevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)The purpose of this study was to determine if eculizumab is safe and could be used to prevent delayed graft function (DGF) following kidney transplantation.NCT02145182·Birmingham, Alabama and 77 others

TerminatedPhase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic CancerGTI-4711-201 is designed as a Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to determine the effect to OS by adding GC4711 to SBRT following…NCT04698915·Gilbert, Arizona and 34 others

TerminatedSC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial CancersThis is a two-part study consisting of Part A (dose regimen finding) followed by Part B (dose expansion).NCT03138408·Birmingham, Alabama and 11 others

TerminatedA Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic SyndromesA Phase 1, an Open-label, Multicenter Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 (RVT-2001) for Subjects With…NCT02841540·Tucson, Arizona and 48 others

CompletedOmnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 DiabetesThe goal of this multi-center, randomized, cross-over study is to evaluate the safety and effectiveness of the Omnipod 5 SmartAdjust 2.0 System in individuals with type 1 or type…NCT06865989·Los Angeles, California and 10 others

CompletedSafety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of ThrombocytopeniaIntensive chemotherapy is associated with significant thrombocytopenia, often requiring platelet transfusion to maintain platelet counts.NCT00039910·Phoenix, Arizona and 37 others

CompletedChemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue SarcomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002791·Birmingham, Alabama and 236 others

Approved for marketingEAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA TxAdvanced Accelerator Applications is currently pursuing marketing approval for 177Lu-DOTA0-Tyr3-Octreotate (Lutathera).NCT02705313·Gilbert, Arizona and 40 others

CompletedP2 Multi-center Study of SB204 Gel in the Treatment of Acne VulgarisThis is a randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris.NCT02242760·Hot Springs, Arkansas and 19 others

RecruitingA Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)The purpose of this study is to evaluate the safety and tolerability of Pumitamig alone or in combination with Ipilimumab in participants with first-line advanced or unresectable…NCT07291076·Duarte, California and 66 others

CompletedStudy to Assess Duration of Indwelling Catheter After SacrocolpopexyObjectives The objective of this study is to help identify the best practice regarding the use of indwelling catheter after minimally invasive urogynecologic surgery.NCT02189291·Detroit, Michigan and 2 others

CompletedA Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target LevelsThe primary objective of this study is to determine the degree of additional reduction in cardiovascular risk that was accrued to patients by lowering their LDL-C beyond the…NCT00327691·Alabaster, Alabama and 313 others

CompletedEfficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)The purpose of this study is to evaluate the efficacy and gather additional safety information for Prochymal® in participants who have failed to respond to steroid treatment of…NCT00366145·Birmingham, Alabama and 69 others

CompletedSurgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenThe primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the preemptive treatment of…NCT01334957·La Jolla, California and 21 others

TerminatedA Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) ExpressionNon-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung.NCT04274907·Birmingham, Alabama and 38 others

CompletedStudy of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)The primary purpose of this study is to assess the safety of AdGVPEDF.11D when given to patients with "wet" age-related macular degeneration (AMD).NCT00109499·Beverly Hills, California and 8 others

CompletedA Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without InhibitorsThis is a randomized, global, multicenter, open-label, Phase 3 clinical study in participants with severe hemophilia A without inhibitors against Factor VIII (FVIII) who are 12…NCT02847637·Santa Monica, California and 38 others

CompletedA Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight GainThe purpose of this study is to assess the percent change in body weight when switching to darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed-dose…NCT04442737·Birmingham, Alabama and 33 others

PreviousPage 158 of 363Next

in Detroit

Heart Diseasein Detroit